301206 三元生物
已收盘 08-23 15:00:00
资讯
新帖
简况
三元生物:不同客户的合作选择通常基于多种因素,与产品质量并无直接关系
证券之星 · 08-24 15:00
三元生物:不同客户的合作选择通常基于多种因素,与产品质量并无直接关系
三元生物:相关情况请参阅公司近日接受“投资者网”首席研究员王健凡先生调研时的公告
证券之星 · 08-15
三元生物:相关情况请参阅公司近日接受“投资者网”首席研究员王健凡先生调研时的公告
三元生物:关于欧盟加征关税的影响,公司已采取多种措施进行调整和优化,以确保生产运营的连续性和效率
证券之星 · 08-05
三元生物:关于欧盟加征关税的影响,公司已采取多种措施进行调整和优化,以确保生产运营的连续性和效率
三元生物(301206)7月31日股东户数1.45万户,较上期减少1.45%
证券之星 · 08-03
三元生物(301206)7月31日股东户数1.45万户,较上期减少1.45%
三元生物:赤藓糖醇占比99%的复配糖通常仅包含赤藓糖醇一种低倍甜味剂
证券之星 · 08-03
三元生物:赤藓糖醇占比99%的复配糖通常仅包含赤藓糖醇一种低倍甜味剂
三元生物(301206)7月31日主力资金净买入54.27万元
证券之星 · 08-01
三元生物(301206)7月31日主力资金净买入54.27万元
【三元生物:公司优质甜菊糖后续将逐步扩产到3000吨/年的产能】金十数据7月27日讯,三元生物7月27日在互动平台表示,公司优质甜菊糖目前以日产几百公斤的产量投放市场,后续将根据市场需求逐步扩产到3000吨/年的产能。
美港电讯 · 07-27
【三元生物:公司优质甜菊糖后续将逐步扩产到3000吨/年的产能】金十数据7月27日讯,三元生物7月27日在互动平台表示,公司优质甜菊糖目前以日产几百公斤的产量投放市场,后续将根据市场需求逐步扩产到3000吨/年的产能。
三元生物:公司在宣传和信息披露方面将采取更加谨慎和务实的态度,以避免不必要的误解和关注
证券之星 · 07-27
三元生物:公司在宣传和信息披露方面将采取更加谨慎和务实的态度,以避免不必要的误解和关注
三元生物(301206)7月24日主力资金净买入849.44万元
证券之星 · 07-25
三元生物(301206)7月24日主力资金净买入849.44万元
7月24日深交所举办第十七期“创享荟”活动聚焦合成生物产业发展邀请华大基因、川宁生物、康弘药业、三元生物、卫光生物、金城药业、华恒生物等合成生物领域相关上市公司代表深圳市合成生物产业私募基金、建设银行等机构代表中科院深圳先进技术研究院合成生物研究所等科研机构代表共话合成生物产业发展支持高水平科技自立自强助力培育壮大新质生产力。
智通财经 · 07-24
7月24日深交所举办第十七期“创享荟”活动聚焦合成生物产业发展邀请华大基因、川宁生物、康弘药业、三元生物、卫光生物、金城药业、华恒生物等合成生物领域相关上市公司代表深圳市合成生物产业私募基金、建设银行等机构代表中科院深圳先进技术研究院合成生物研究所等科研机构代表共话合成生物产业发展支持高水平科技自立自强助力培育壮大新质生产力。
三元生物7月23日现7笔大宗交易 成交金额1.05亿元
智能小浪 · 07-23
三元生物7月23日现7笔大宗交易 成交金额1.05亿元
7月23日三元生物现6笔溢价13.21%的大宗交易 合计成交1.05亿元
证券之星 · 07-23
7月23日三元生物现6笔溢价13.21%的大宗交易 合计成交1.05亿元
三元生物:7月19日高管聂在建增持股份合计19.16万股
证券之星 · 07-19
三元生物:7月19日高管聂在建增持股份合计19.16万股
三元生物(301206.SZ)实控人增持19.16万股
智通财经 · 07-19
三元生物(301206.SZ)实控人增持19.16万股
【三元生物(301206.SZ)实控人增持19.16万股】智通财经APP讯,三元生物(301206.SZ)公告,2024年7月19日,公司控股股东、实际控制人、董事长聂在建以集中竞价方式增持公司股份19.
智通财经 · 07-19
【三元生物(301206.SZ)实控人增持19.16万股】智通财经APP讯,三元生物(301206.SZ)公告,2024年7月19日,公司控股股东、实际控制人、董事长聂在建以集中竞价方式增持公司股份19.
三元生物:赤藓糖醇产品被欧盟委员会裁定征收156.7%的临时反倾销税三元生物公告,欧盟委员会7月19日公布了关于赤藓糖醇反倾销调查初裁公告,公司涉案产品赤藓糖醇(纯赤藓糖醇或混合后其他产品含量低于10%的赤藓糖醇)产品被征收156.
格隆汇 · 07-19
三元生物:赤藓糖醇产品被欧盟委员会裁定征收156.7%的临时反倾销税三元生物公告,欧盟委员会7月19日公布了关于赤藓糖醇反倾销调查初裁公告,公司涉案产品赤藓糖醇(纯赤藓糖醇或混合后其他产品含量低于10%的赤藓糖醇)产品被征收156.
三元生物:拟以集中竞价交易方式回购股份,回购价格不超过35元/股,回购金额不低于5000万元且不超过1亿元。
美港电讯 · 07-15
三元生物:拟以集中竞价交易方式回购股份,回购价格不超过35元/股,回购金额不低于5000万元且不超过1亿元。
三元生物(301206.SZ)实控人拟斥500万元到1000万元增持股份
智通财经 · 07-08
三元生物(301206.SZ)实控人拟斥500万元到1000万元增持股份
三元生物(301206.SZ)拟斥0.5亿元到1亿元回购股份
智通财经网 · 07-08
三元生物(301206.SZ)拟斥0.5亿元到1亿元回购股份
【三元生物(301206.SZ)拟斥0.5亿元到1亿元回购股份】智通财经APP讯,三元生物(301206.SZ)发布公告,公司拟通过深圳证券交易所交易系统以集中竞价交易方式回购公司股份用于后期实施股权激励或员工持股计划。
智通财经 · 07-08
【三元生物(301206.SZ)拟斥0.5亿元到1亿元回购股份】智通财经APP讯,三元生物(301206.SZ)发布公告,公司拟通过深圳证券交易所交易系统以集中竞价交易方式回购公司股份用于后期实施股权激励或员工持股计划。
加载更多
公司概况
公司名称:
山东三元生物科技股份有限公司
所属行业:
食品制造业
上市日期:
2022-02-10
主营业务:
山东三元生物科技股份有限公司主营业务是功能糖赤藓糖醇和阿洛酮糖产品的研发、生产和销售。公司的主要产品是赤藓糖醇及复配糖、阿洛酮糖。公司主要产品赤藓糖醇生产能力为13.5万吨,是目前全球规模最大的赤藓糖醇生产企业,在赤藓糖醇行业内具有良好的口碑和较强的品牌优势,公司生产的天绿原牌赤藓糖醇被评为“山东优质品牌”和“山东知名品牌”。
发行价格:
109.30
{"stockData":{"symbol":"301206","market":"SZ","secType":"STK","nameCN":"三元生物","latestPrice":23.94,"timestamp":1724396619000,"preClose":24.22,"halted":0,"volume":404900,"delay":0,"floatShares":104000000,"shares":202000000,"eps":0.3723,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.28,"latestTime":"08-23 15:00:00","open":24.12,"high":24.39,"low":23.55,"amount":9664000,"amplitude":0.0347,"askPrice":23.94,"askSize":15,"bidPrice":23.87,"bidSize":10,"shortable":0,"etf":0,"ttmEps":0.3723,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724635800000},"adr":0,"adjPreClose":24.22,"symbolType":"stock","openAndCloseTimeList":[[1724376600000,1724383800000],[1724389200000,1724396400000]],"highLimit":26.64,"lowLimit":21.8,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":202325700,"pbRate":1.07,"roa":"--","roe":"0.53%","epsLYR":0.29,"committee":-0.626667,"marketValue":4844000000,"floatMarketCap":2479000000,"peRate":64.302982,"changeRate":-0.0116,"turnoverRate":0.0039,"status":1},"requestUrl":"/m/hq/s/301206","defaultTab":"news","newsList":[{"id":"2461853056","title":"三元生物:不同客户的合作选择通常基于多种因素,与产品质量并无直接关系","url":"https://stock-news.laohu8.com/highlight/detail?id=2461853056","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461853056?lang=zh_cn&edition=full","pubTime":"2024-08-24 15:00","pubTimestamp":1724482834,"startTime":"0","endTime":"0","summary":"证券之星消息,三元生物08月24日在投资者关系平台上答复投资者关心的问题。不同客户的合作选择通常基于多种因素,与产品质量并无直接关系。甜菊糖苷已有百年的食用历史,其安全性得到了广泛认可。塔格糖目前正在积极推进中试工作,力争早日实现规模化生产。大华会计师事务所2024年被暂停证券业务6个月,以及公司签字会计师滕忠诚2022年收到警示函均与公司无关。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082400009107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2459449479","title":"三元生物:相关情况请参阅公司近日接受“投资者网”首席研究员王健凡先生调研时的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2459449479","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459449479?lang=zh_cn&edition=full","pubTime":"2024-08-15 18:04","pubTimestamp":1723716268,"startTime":"0","endTime":"0","summary":"证券之星消息,三元生物08月15日在投资者关系平台上答复投资者关心的问题。相关情况请参阅公司近日接受“投资者网”首席研究员王健凡先生调研时的公告。研发投入情况请查阅公司年度报告中的相关信息。总体而言,随着消费者健康意识的增强,这些市场的需求呈现出持续增长的趋势,公司将密切关注并积极拓展这些市场。敬请关注后续公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081500036678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2457474987","title":"三元生物:关于欧盟加征关税的影响,公司已采取多种措施进行调整和优化,以确保生产运营的连续性和效率","url":"https://stock-news.laohu8.com/highlight/detail?id=2457474987","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457474987?lang=zh_cn&edition=full","pubTime":"2024-08-05 17:04","pubTimestamp":1722848669,"startTime":"0","endTime":"0","summary":"关于欧盟加征关税的影响,公司已采取多种措施进行调整和优化,以确保生产运营的连续性和效率。欧盟加征关税会对公司赤藓糖醇在该市场的竞争力和销售情况产生影响,与生产成本没有直接关系。公司正在积极采取多种应对措施,以尽量减少这一影响,并维护现有客户关系。公司目前尚未生产柠檬酸 。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080500023548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2456210783","title":"三元生物(301206)7月31日股东户数1.45万户,较上期减少1.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456210783","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456210783?lang=zh_cn&edition=full","pubTime":"2024-08-03 16:59","pubTimestamp":1722675571,"startTime":"0","endTime":"0","summary":"证券之星消息,近日三元生物披露,截至2024年7月31日公司股东户数为1.45万户,较7月19日减少213.0户,减幅为1.45%。在化学制品行业个股中,三元生物股东户数低于行业平均水平,截至7月31日,化学制品行业平均股东户数为2.56万户。从股价来看,2024年7月19日至2024年7月31日,三元生物区间涨幅为4.5%,在此期间股东户数减少213.0户,减幅为1.45%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080300014985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2456142212","title":"三元生物:赤藓糖醇占比99%的复配糖通常仅包含赤藓糖醇一种低倍甜味剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2456142212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456142212?lang=zh_cn&edition=full","pubTime":"2024-08-03 16:00","pubTimestamp":1722672036,"startTime":"0","endTime":"0","summary":"赤藓糖醇占比99%的复配糖通常仅包含赤藓糖醇一种低倍甜味剂。甜菊糖苷及其衍生物属于天然的非糖甜味剂。赤藓糖醇目前仍然广泛应用于食品和饮料行业,尤其是作为天然、低热量甜味剂的替代品,市场需求稳定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080300014902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2456108031","title":"三元生物(301206)7月31日主力资金净买入54.27万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456108031","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456108031?lang=zh_cn&edition=full","pubTime":"2024-08-01 09:25","pubTimestamp":1722475504,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月31日收盘,三元生物报收于25.56元,上涨1.03%,换手率1.18%,成交量1.22万手,成交额3105.43万元。近5日资金流向一览见下表:三元生物融资融券信息显示,融资方面,当日融资买入305.56万元,融资偿还339.48万元,融资净偿还33.93万元。三元生物主营业务:主要从事功能糖赤藓糖醇和阿洛酮糖产品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080100014261.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2454554256","title":"【三元生物:公司优质甜菊糖后续将逐步扩产到3000吨/年的产能】金十数据7月27日讯,三元生物7月27日在互动平台表示,公司优质甜菊糖目前以日产几百公斤的产量投放市场,后续将根据市场需求逐步扩产到3000吨/年的产能。","url":"https://stock-news.laohu8.com/highlight/detail?id=2454554256","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454554256?lang=zh_cn&edition=full","pubTime":"2024-07-27 22:01","pubTimestamp":1722088890,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2454581867","title":"三元生物:公司在宣传和信息披露方面将采取更加谨慎和务实的态度,以避免不必要的误解和关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2454581867","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454581867?lang=zh_cn&edition=full","pubTime":"2024-07-27 11:00","pubTimestamp":1722049230,"startTime":"0","endTime":"0","summary":"公司上半年经营状况良好,敬请关注后续披露的半年度报告。如果公司如实宣传也不会引起了欧盟委员会注意。感谢您的宝贵建议,公司在宣传和信息披露方面将采取更加谨慎和务实的态度,以避免不必要的误解和关注。公司正在积极调整和优化销售策略,以确保公司在市场中的竞争力。因涉及商业敏感信息,公司不便公开相关数据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072700012839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2454553861","title":"三元生物(301206)7月24日主力资金净买入849.44万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454553861","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454553861?lang=zh_cn&edition=full","pubTime":"2024-07-25 09:11","pubTimestamp":1721869909,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月24日收盘,三元生物报收于25.16元,上涨5.49%,换手率2.4%,成交量2.48万手,成交额6196.64万元。近5日资金流向一览见下表:三元生物融资融券信息显示,融资方面,当日融资买入510.96万元,融资偿还388.54万元,融资净买入122.42万元。三元生物主营业务:主要从事功能糖赤藓糖醇和阿洛酮糖产品的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072500014393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2453006341","title":"7月24日深交所举办第十七期“创享荟”活动聚焦合成生物产业发展邀请华大基因、川宁生物、康弘药业、三元生物、卫光生物、金城药业、华恒生物等合成生物领域相关上市公司代表深圳市合成生物产业私募基金、建设银行等机构代表中科院深圳先进技术研究院合成生物研究所等科研机构代表共话合成生物产业发展支持高水平科技自立自强助力培育壮大新质生产力。","url":"https://stock-news.laohu8.com/highlight/detail?id=2453006341","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453006341?lang=zh_cn&edition=full","pubTime":"2024-07-24 20:01","pubTimestamp":1721822474,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["601939","LU1997245177.USD","BK0015","BK0183","LU0052750758.USD","IE00B0JY6N72.USD","LU0293314216.USD","LU0084288322.USD","LU0173614495.USD","BK1560","LU0287142896.SGD","LU1997244956.HKD","LU0259732245.USD","LU0043850808.USD","LU0417516738.SGD","LU0516422440.USD","LU0096374516.USD","002880","BK1521","IE00B3M56506.USD","IE00BWDBJ730.SGD","LU0348735423.USD","LU0348827113.USD","LU2495084118.USD","LU0149721374.USD","00939","LU0348825331.USD","BK0197","LU0633140560.USD","LU0417516902.SGD","301301","002773","BK0042","HK0000320264.USD","LU0163747925.USD","LU1997245094.SGD","BK0239","BK0221","301206","HK0000320223.HKD","BK1231","LU0359201612.USD","LU0572944931.SGD","LU0061477393.USD","03143","LU0634319403.HKD","300676","688639","BK0175","LU0348805143.USD"],"gpt_icon":0},{"id":"2453708582","title":"三元生物7月23日现7笔大宗交易 成交金额1.05亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453708582","media":"智能小浪","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453708582?lang=zh_cn&edition=full","pubTime":"2024-07-23 17:00","pubTimestamp":1721725200,"startTime":"0","endTime":"0","summary":" 7月23日,三元生物收跌1.24%,收盘价为23.85元,发生7笔大宗交易,合计成交量396.61万股,成交金额1.05亿元。 第3笔成交价格为27.00元,成交39.89万股,成交金额1,077.03万元,溢价率为13.21%,买方营业部为财通证券股份有限公司绍兴人民中路证券营业部,卖方营业部为海通证券股份有限公司绍兴劳动路证券营业部。 进一步统计,近3个月内该股累计发生7笔大宗交易,合计成交金额为1.05亿元。该股近5个交易日累计下跌1.77%,主力资金合计净流入215.76万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2024-07-23/doc-incfchwx3469734.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-07-23/doc-incfchwx3469734.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2453088555","title":"7月23日三元生物现6笔溢价13.21%的大宗交易 合计成交1.05亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453088555","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453088555?lang=zh_cn&edition=full","pubTime":"2024-07-23 16:40","pubTimestamp":1721724034,"startTime":"0","endTime":"0","summary":"证券之星消息,7月23日三元生物发生大宗交易,交易数据如下:近三个月该股共发生7笔大宗交易,合计成交3.97万手,溢价成交7笔。该股近期无解禁股上市。截至2024年7月23日收盘,三元生物报收于23.85元,下跌1.24%,换手率1.04%,成交量1.08万手,成交额2618.65万元。该股最近90天内共有1家机构给出评级,中性评级1家;过去90天内机构目标均价为31.72。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072300030751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2452753484","title":"三元生物:7月19日高管聂在建增持股份合计19.16万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452753484","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452753484?lang=zh_cn&edition=full","pubTime":"2024-07-19 20:01","pubTimestamp":1721390470,"startTime":"0","endTime":"0","summary":"证券之星消息,根据7月19日市场公开信息、上市公司公告及交易所披露数据整理,三元生物最新董监高及相关人员股份变动情况:2024年7月19日公司董事长聂在建共增持公司股份19.16万股,占公司总股本为0.0947%。三元生物近半年内的董监高及核心技术人员增减持详情如下:三元生物的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出179.54万,融资余额减少;融券净流出1000.0,融券余额减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071900047480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2452242128","title":"三元生物(301206.SZ)实控人增持19.16万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452242128","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452242128?lang=zh_cn&edition=full","pubTime":"2024-07-19 19:17","pubTimestamp":1721387874,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三元生物(301206.SZ)公告,2024年7月19日,公司控股股东、实际控制人、董事长聂在建以集中竞价方式增持公司股份19.16万股,占公司当前总股本的0.09%。本次增持计划尚未实施完毕,增持主体将继续按照增持计划,在增持计划实施时间内增持公司股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153402.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2452217734","title":"【三元生物(301206.SZ)实控人增持19.16万股】智通财经APP讯,三元生物(301206.SZ)公告,2024年7月19日,公司控股股东、实际控制人、董事长聂在建以集中竞价方式增持公司股份19.","url":"https://stock-news.laohu8.com/highlight/detail?id=2452217734","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452217734?lang=zh_cn&edition=full","pubTime":"2024-07-19 19:17","pubTimestamp":1721387874,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2452421777","title":"三元生物:赤藓糖醇产品被欧盟委员会裁定征收156.7%的临时反倾销税三元生物公告,欧盟委员会7月19日公布了关于赤藓糖醇反倾销调查初裁公告,公司涉案产品赤藓糖醇(纯赤藓糖醇或混合后其他产品含量低于10%的赤藓糖醇)产品被征收156.","url":"https://stock-news.laohu8.com/highlight/detail?id=2452421777","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452421777?lang=zh_cn&edition=full","pubTime":"2024-07-19 19:14","pubTimestamp":1721387653,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2451961283","title":"三元生物:拟以集中竞价交易方式回购股份,回购价格不超过35元/股,回购金额不低于5000万元且不超过1亿元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2451961283","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451961283?lang=zh_cn&edition=full","pubTime":"2024-07-15 18:07","pubTimestamp":1721038056,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2449040776","title":"三元生物(301206.SZ)实控人拟斥500万元到1000万元增持股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2449040776","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449040776?lang=zh_cn&edition=full","pubTime":"2024-07-08 19:34","pubTimestamp":1720438461,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三元生物(301206.SZ)发布公告,公司于近日收到控股股东、实际控制人、董事长聂在建出具的《关于增持公司股份计划的告知函》,拟增持金额不低于人民币500万元且不超过人民币1000万元。本次增持股份计划的实施期限自本公告披露之日起6个月内。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1147209.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2449776211","title":"三元生物(301206.SZ)拟斥0.5亿元到1亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2449776211","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449776211?lang=zh_cn&edition=full","pubTime":"2024-07-08 19:32","pubTimestamp":1720438340,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三元生物(301206.SZ)发布公告,公司拟通过深圳证券交易所交易系统以集中竞价交易方式回购公司股份用于后期实施股权激励或员工持股计划。回购股份资金总额不低于人民币5000万元(含),且不超过人民币10000万元(含)。回购股份价格不超过35元/股(含)。回购股份实施期限自第四届董事会第二十三次会议审议通过回购股份方案之日起不超过12个月。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1147206.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2449577629","title":"【三元生物(301206.SZ)拟斥0.5亿元到1亿元回购股份】智通财经APP讯,三元生物(301206.SZ)发布公告,公司拟通过深圳证券交易所交易系统以集中竞价交易方式回购公司股份用于后期实施股权激励或员工持股计划。","url":"https://stock-news.laohu8.com/highlight/detail?id=2449577629","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449577629?lang=zh_cn&edition=full","pubTime":"2024-07-08 19:32","pubTimestamp":1720438340,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["301206","BK0226","399001"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-02-10","address":"山东省滨州市滨城区滨北张富路89号","stockEarnings":[{"period":"1week","weight":-0.0424},{"period":"1month","weight":-0.0485},{"period":"3month","weight":-0.1449},{"period":"6month","weight":-0.033},{"period":"1year","weight":-0.1542},{"period":"ytd","weight":-0.1636}],"companyName":"山东三元生物科技股份有限公司","boardCode":"AI0014","perCapita":"7151股","boardName":"食品制造业","registeredCapital":"20232万元","compareEarnings":[{"period":"1week","weight":-0.0087},{"period":"1month","weight":-0.0164},{"period":"3month","weight":-0.0759},{"period":"6month","weight":-0.0501},{"period":"1year","weight":-0.0739},{"period":"ytd","weight":-0.0405}],"survey":" 山东三元生物科技股份有限公司主营业务是功能糖赤藓糖醇和阿洛酮糖产品的研发、生产和销售。公司的主要产品是赤藓糖醇及复配糖、阿洛酮糖。公司主要产品赤藓糖醇生产能力为13.5万吨,是目前全球规模最大的赤藓糖醇生产企业,在赤藓糖醇行业内具有良好的口碑和较强的品牌优势,公司生产的天绿原牌赤藓糖醇被评为“山东优质品牌”和“山东知名品牌”。","serverTime":1724546614174,"listedPrice":109.3,"stockholders":"14478人(较上一季度减少1.45%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三元生物(301206)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三元生物(301206)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三元生物,301206,三元生物股票,三元生物股票老虎,三元生物股票老虎国际,三元生物行情,三元生物股票行情,三元生物股价,三元生物股市,三元生物股票价格,三元生物股票交易,三元生物股票购买,三元生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三元生物(301206)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三元生物(301206)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}